GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tristel PLC (OTCPK:TSNLF) » Definitions » Forward PE Ratio

Tristel (Tristel) Forward PE Ratio : 26.04 (As of Jun. 10, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Tristel Forward PE Ratio?

Tristel's Forward PE Ratio for today is 26.04.

Tristel's PE Ratio without NRI for today is 34.40.

Tristel's PE Ratio for today is 34.40.


Tristel Forward PE Ratio Historical Data

The historical data trend for Tristel's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tristel Forward PE Ratio Chart

Tristel Annual Data
Trend 2016-04 2022-10 2023-11 2024-06
Forward PE Ratio
13.57 10.78 33.33 25.06

Tristel Semi-Annual Data
2024-06
Forward PE Ratio 25.06

Competitive Comparison of Tristel's Forward PE Ratio

For the Medical Instruments & Supplies subindustry, Tristel's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tristel's Forward PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tristel's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Tristel's Forward PE Ratio falls into.



Tristel Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Tristel  (OTCPK:TSNLF) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Tristel Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Tristel's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Tristel (Tristel) Business Description

Traded in Other Exchanges
Address
Fordham Road, Unit 1B, Lynx Business Park, Newmarket, Snailwell, Cambridgeshire, GBR, CB8 7NY
Tristel PLC is a player in the healthcare platform. The company is a manufacturer of chlorine dioxide chemistry used for the decontamination of medical devices. Its operating segments include three sectors, Hospital medical device decontamination products which are used predominantly for infection control in hospitals; manufacture and sale of hospital environmental surface disinfection products; and pharmaceutical and personal care product manufacturing industries, veterinary and animal welfare. The company generates majority of revenue from Hospital medical device decontamination.

Tristel (Tristel) Headlines

From GuruFocus